Health start up Athelas hits $ 1.5 billion valuation after pandemic boom
- ByStartupStory | February 1, 2022
Athelas’ primary product is the Athelas one, an Internet- connected device that uses a finger- prick to return blood diagnostics and allots the information with the health care services.
Discovered in 2016, Athelas expertise in sharp growth last year, spurred in part by a shift to remote care during the covid- 19 pandemic
Athelas Inc., a start up that empowers remote patient monitoring technology, risen $ 132 million in new funding, bringing its valuation to $ 1.5 billion.
It also went through acrid growth last year, spurred in part by a shift to utter care during the pandemic.
Athelas now has 20,000 patients, 10 times the number of patients it had in the beginning of 2021, co- founder and chief executive officer tanay Tandon said, “ This has really displayed to people that health care in the home has to be a thing and in a lot of ways is better than the traditional care model,” Tandon said.
Athelas’ primary product is the Athelas one, an Internet- connected device that uses a finger –
Prick to return blood diagnostics and allots that information with health care providers.
The product, which has been approved by the federal Drug Administrative is equipped towards patients who are immunco comprised or have chronic effects that need constant monitoring enables doctors to address health care issues earlier, assuredly avoiding the pricers costs of more intensive treatment or hospitalisation down the road.
Follow Startup Story
Related Posts
